US Patent 10799453 Amlodipine formulations
Patent 10799453 was granted and assigned to Silvergate Pharmaceuticals, Inc. on October, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 11, 2019
Date of Patent
October 13, 2020
Patent Applicant
Patent Application Number
16381575
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10799453 Amlodipine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.